Cargando…
Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382111/ https://www.ncbi.nlm.nih.gov/pubmed/27991896 http://dx.doi.org/10.1038/bmt.2016.330 |
| _version_ | 1782520040524873728 |
|---|---|
| author | Perez, Lia Elena Fernandez, Hugo Ayala, Ernesto Beato, Francisca Neuger, Anthony Pidala, Joseph Schell, Michael J. Anasetti, Claudio |
| author_facet | Perez, Lia Elena Fernandez, Hugo Ayala, Ernesto Beato, Francisca Neuger, Anthony Pidala, Joseph Schell, Michael J. Anasetti, Claudio |
| author_sort | Perez, Lia Elena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5382111 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53821112017-06-19 Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors Perez, Lia Elena Fernandez, Hugo Ayala, Ernesto Beato, Francisca Neuger, Anthony Pidala, Joseph Schell, Michael J. Anasetti, Claudio Bone Marrow Transplant Article 2016-12-19 2017-04 /pmc/articles/PMC5382111/ /pubmed/27991896 http://dx.doi.org/10.1038/bmt.2016.330 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
| spellingShingle | Article Perez, Lia Elena Fernandez, Hugo Ayala, Ernesto Beato, Francisca Neuger, Anthony Pidala, Joseph Schell, Michael J. Anasetti, Claudio Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors |
| title | Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors |
| title_full | Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors |
| title_fullStr | Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors |
| title_full_unstemmed | Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors |
| title_short | Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors |
| title_sort | visilizumab with tacrolimus and methotrexate for graft-versus-host disease prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382111/ https://www.ncbi.nlm.nih.gov/pubmed/27991896 http://dx.doi.org/10.1038/bmt.2016.330 |
| work_keys_str_mv | AT perezliaelena visilizumabwithtacrolimusandmethotrexateforgraftversushostdiseasepreventionafterallogeneichematopoieticcelltransplantationfrommismatchedunrelateddonors AT fernandezhugo visilizumabwithtacrolimusandmethotrexateforgraftversushostdiseasepreventionafterallogeneichematopoieticcelltransplantationfrommismatchedunrelateddonors AT ayalaernesto visilizumabwithtacrolimusandmethotrexateforgraftversushostdiseasepreventionafterallogeneichematopoieticcelltransplantationfrommismatchedunrelateddonors AT beatofrancisca visilizumabwithtacrolimusandmethotrexateforgraftversushostdiseasepreventionafterallogeneichematopoieticcelltransplantationfrommismatchedunrelateddonors AT neugeranthony visilizumabwithtacrolimusandmethotrexateforgraftversushostdiseasepreventionafterallogeneichematopoieticcelltransplantationfrommismatchedunrelateddonors AT pidalajoseph visilizumabwithtacrolimusandmethotrexateforgraftversushostdiseasepreventionafterallogeneichematopoieticcelltransplantationfrommismatchedunrelateddonors AT schellmichaelj visilizumabwithtacrolimusandmethotrexateforgraftversushostdiseasepreventionafterallogeneichematopoieticcelltransplantationfrommismatchedunrelateddonors AT anasetticlaudio visilizumabwithtacrolimusandmethotrexateforgraftversushostdiseasepreventionafterallogeneichematopoieticcelltransplantationfrommismatchedunrelateddonors |